World News: 11:00 GMT Friday 12th July 2019. [Genmab A/S via Globe Newswire via SPi World News]
With this agreement the scope of productunder development at Genmab has been expanded CD47 has shown as a target for cancer and we that a bispecific approach may open up potential for differentiated therapies We are always ...
Globe Newswire: 11:00 GMT Friday 12th July 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.